Leveraging artificial intelligence and human expertise to expand the knowledge frontier of molecules by innovating in indication discovery to optimise, accelerate, and de-risk drug development. Our expertise closes the translational gap between advanced analytics, complex biology, and market dynamics, providing our pharmaceutical and biotechnological partners with a holistic strategic roadmap of their assets and bringing treatments to patients sooner.